These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 21194771)

  • 1. Angiotensin-(1-7): a new therapeutic strategy in the management of atrial fibrillation.
    Li Y; Li G; Liu T
    Int J Cardiol; 2011 Mar; 147(2):287-8. PubMed ID: 21194771
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin-(1-7) as a strategy in the treatment of hypertension?
    van Twist DJ; Kroon AA; de Leeuw PW
    Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):480-6. PubMed ID: 25023950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of atrial fibrillation: insights into the renin-angiotensin system.
    Le Heuzey JY; Marijon E; Chachoua K; Waintraub X; Lepillier A; Otmani A; Lavergne T; Pornin M
    Arch Cardiovasc Dis; 2008; 101(11-12):787-91. PubMed ID: 19059574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives.
    Iusuf D; Henning RH; van Gilst WH; Roks AJ
    Eur J Pharmacol; 2008 May; 585(2-3):303-12. PubMed ID: 18417117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Are ACE inhibitors and angiotensin receptor blockers useful in the treatment of atrial fibrillation?].
    Raatikainen MJ; Huikuri HV
    Duodecim; 2003; 119(16):1505-7. PubMed ID: 14535023
    [No Abstract]   [Full Text] [Related]  

  • 6. The angiotensin-converting enzyme 2-angiotensin-(1-7) axis: the other side of the renin-angiotensin system.
    Shahid M
    Exp Physiol; 2011 Oct; 96(10):987-8. PubMed ID: 21914857
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin (1-7) prevent heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5/6 nephrectomy mice.
    Li Y; Wu J; He Q; Shou Z; Zhang P; Pen W; Zhu Y; Chen J
    Hypertens Res; 2009 May; 32(5):369-74. PubMed ID: 19325560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of hypertension in patients with atrial fibrillation. Sartan is superior to beta-blocker].
    MMW Fortschr Med; 2003 May; 145(19):53. PubMed ID: 12813983
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin-(1-7) prevent atrial tachycardia induced sodium channel remodeling.
    Wang X; Li G
    Pacing Clin Electrophysiol; 2014 Oct; 37(10):1349-56. PubMed ID: 24861429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atrial fibrillation as end point of hypertension. Can antihypertensive therapy prevent it?].
    Geller JC
    MMW Fortschr Med; 2003 Nov; 145(47):38-41. PubMed ID: 14725032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin 1-7 and risk for breast cancer recurrence.
    Altundag K; Altundag O; Akyurek S; Silay K; Turen S
    Cancer Chemother Pharmacol; 2006 Aug; 58(2):283; author reply 284. PubMed ID: 16328412
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin (1-7) as a therapy to prevent rupture of intracranial aneurysms?
    Kuruppu S; Smith AI; Drummond GR; Sobey CG
    Hypertension; 2014 Aug; 64(2):222-3. PubMed ID: 24799616
    [No Abstract]   [Full Text] [Related]  

  • 13. Approach to management of atrial fibrillation in the Indian scenario.
    Vora A
    J Assoc Physicians India; 2007 Apr; 55 Suppl():30-2. PubMed ID: 18368864
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of rate and rhythm control on blood pressure and antihypertensive drug usage in patients with atrial fibrillation and hypertension enrolled in the AFFIRM trial.
    Masood SO; Wasmund SL; Akoum NW; Egger MJ; Hsiai T; Hamdan MH
    J Cardiovasc Electrophysiol; 2010 Oct; 21(10):1094-8. PubMed ID: 20455988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensins and the heart: is angiotensin-(1-7) cardioprotective?
    Wysocki J; Wilsbacher L; Batlle D
    Hypertension; 2015 Aug; 66(2):260-2. PubMed ID: 26077564
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetic nephropathy: Renoprotective effects of angiotensin 1-7.
    Carney EF
    Nat Rev Nephrol; 2014 May; 10(5):240. PubMed ID: 24614408
    [No Abstract]   [Full Text] [Related]  

  • 17. New therapeutic pathways in the RAS.
    Bader M; Santos RA; Unger T; Steckelings UM
    J Renin Angiotensin Aldosterone Syst; 2012 Dec; 13(4):505-8. PubMed ID: 23166114
    [No Abstract]   [Full Text] [Related]  

  • 18. Antihypertensive treatment and risk of atrial fibrillation: a nationwide study.
    Marott SC; Nielsen SF; Benn M; Nordestgaard BG
    Eur Heart J; 2014 May; 35(18):1205-14. PubMed ID: 24347316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agents with antialdosterone properties should be the preferred diuretics for reducing hypertension related atrial fibrillation.
    Jolobe OM
    Eur J Intern Med; 2010 Feb; 21(1):55. PubMed ID: 20122621
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.
    Schaer BA; Schneider C; Jick SS; Conen D; Osswald S; Meier CR
    Ann Intern Med; 2010 Jan; 152(2):78-84. PubMed ID: 20083826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.